The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
About this item
Full title
Author / Creator
Publisher
Los Angeles, CA: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
Los Angeles, CA: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Drug-induced thrombotic microangiopathy (DITMA) is a secondary cause of thrombotic microangiopathy and a potentially fatal inflammatory disease. DITMA has been attributed to a variety of drugs, particularly chemotherapeutic and immunosuppressive agents. Prompt diagnosis is critical for survival and treatment necessitates withdrawal of the offending...
Alternative Titles
Full title
The Use of Eculizumab in Tacrolimus-Induced Thrombotic Microangiopathy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_65f89a54ac954d14b4ab079c08e1621d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_65f89a54ac954d14b4ab079c08e1621d
Other Identifiers
ISSN
2324-7096
E-ISSN
2324-7096
DOI
10.1177/2324709620947266
